文献速递血液净化与透析

腹膜透析技术生存率的队列研究

Peritoneal Dialysis Technique Survival: A Cohort Study.
PubMed 文献 · Am J Kidney Dis · 2024-04-17

该回顾性队列研究纳入2010至2019年间在DCI门诊启动腹膜透析的5224例成人患者,评估临床因素与PD技术生存的关联。发现以PD起始透析者技术生存更优,而PD早期或晚期转换者转HD风险更高;腹膜炎、低白蛋白和低Kt/V是可干预风险因素。

要点

  • 以PD起始透析与更长的PD维持时间相关。
  • PD早期或晚期转换者转HD风险高于PD起始者。
  • 腹膜炎、低血清白蛋白和低Kt/V是转HD的可干预风险因素。

核心结论

  • 以PD起始透析与更高的PD技术生存相关,但晚期转换者仍能维持较长时间PD。
  • 腹膜炎、低血清白蛋白和低Kt/V是PD转HD的可干预风险因素。

研究设计与样本

  • 回顾性队列研究,纳入2010年1月1日至2019年9月30日在DCI门诊启动PD的成人患者,共5224例。

主要发现

  • 3174例以PD起始透析,942例在90天内从HD转PD,1108例在90天后从HD转PD;1472例(28%)随后从PD转HD。
  • 与PD起始者相比,PD早期转换者前9个月调整风险比1.51(95%CI 1.17-1.96),9个月后1.16(95%CI 0.99-1.35)。
  • PD晚期转换者前9个月调整风险比2.41(95%CI 1.94-3.00),9个月后1.43(95%CI 1.24-1.65)。
  • 更多腹膜炎发作、更少家庭访视、较低血清白蛋白、较低残余肾功能和较低每周Kt/V腹膜清除率是转HD的额外风险因素。

临床怎么用

  • 优先考虑以PD起始透析可能改善PD技术生存。
  • 对PD患者应积极预防腹膜炎、纠正低白蛋白并优化Kt/V以降低转HD风险。

局限性

  • 透析充分性和残余肾功能数据缺失,且受PD技术生存时间短的混杂影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Reasons for transfer from peritoneal dialysis (PD) to hemodialysis (HD) remain incompletely understood. Among incident and prevalent patients receiving PD, we evaluated the association of clinical factors, including prior treatment with HD, with PD technique survival. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: Adults who initiated PD at a Dialysis Clinic, Inc (DCI) outpatient facility between January 1, 2010, and September 30, 2019. EXPOSURE: The primary exposure of interest was timing of PD start, categorized as PD-first, PD-early, or PD-late. Other covariates included demographics, clinical characteristics, and routine laboratory results. OUTCOME: Modality switch from PD to HD sustained for more than 90 days. ANALYTICAL APPROACH: Multivariable Fine-Gray models with competing risks and time-varying covariates, stratified at 9 months to account for lack of proportionality. RESULTS: Among 5,224 patients who initiated PD at a DCI facility, 3,174 initiated dialysis with PD ("PD-first"), 942 transitioned from HD to PD within 90 days ("PD-early"), and 1,108 transitioned beyond 90 days ("PD-late"); 1,472 (28%) subsequently transferred from PD to HD. The PD-early and PD-late patients had a higher risk of transfer to HD as compared with PD-first patients (in the first 9 months: adjusted hazard ratio [AHR], 1.51 [95% CI, 1.17-1.96] and 2.41 [95% CI, 1.94-3.00], respectively; and after 9 months: AHR, 1.16 [95% CI, 0.99-1.35] and AHR, 1.43 [95% CI, 1.24-1.65], respectively). More peritonitis episodes, fewer home visits, lower serum albumin levels, lower residual kidney function, and lower peritoneal clearance calculated with weekly Kt/V were additional risk factors for PD-to-HD transfer. LIMITATIONS: Missing data on dialysis adequacy and residual kidney function, confounded by short PD technique survival. CONCLUSIONS: Initiating dialysis with PD is associated with greater PD technique survival, though many of those who initiate PD-late in their dialysis course still experience substantial time on PD. Peritonitis, lower serum albumin, and lower Kt/V are risk factors for PD-to-HD transfer that may be amenable to intervention. PLAIN-LANGUAGE SUMMARY: Peritoneal dialysis (PD) is an important kidney replacement modality with several potential advantages compared with in-center hemodialysis (HD). However, a substantial number of patients transfer to in-center HD early on, without having experienced the quality-of-life and other benefits that come with sustained maintenance of PD. Using retrospective data from a midsize national dialysis provider, we found that initiating dialysis with PD is associated with longer maintenance of PD, compared with initiating dialysis with HD and a later switch to PD. However, many of those who initiate PD-late in their dialysis course still experience substantial time on PD. Peritonitis, lower serum albumin, and lower small protein removal are other risk factors for PD-to-HD transfer that may be amenable to intervention.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Hsu CM, Li NC, Lacson EK, et al. Peritoneal Dialysis Technique Survival: A Cohort Study. Am J Kidney Dis. 2024. PMID: 38640994. doi:10.1053/j.ajkd.2024.03.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。